Contineum Therapeutics, Inc. Class A Common Stock (CTNM)

Typically moves ±4.37% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-10-13 APPROXIMATE
search

Since May 16, 2024, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has reported earnings 10 times. On average the shares move ±4.37% post-earnings, with a positive reaction 90.0% of the time. Its largest post-earnings gain was +8.27% (Aug 13, 2024) and its largest decline was -1.65% (Jul 30, 2026). The next earnings report is predicted for 2026-10-13 (approximate).

Earnings reactions

How CTNM moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

10

Avg Abs. Movement

±4.37%

Positive %

90.0%

Negative %

10.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Jul 30, 2026 ☽ POST -1.65% open_in_new
May 05, 2026 ☽ POST +3.62% open_in_new
Mar 05, 2026 ☽ POST +0.25% open_in_new
Oct 30, 2025 ☽ POST +4.41% open_in_new
event

Earnings Count

10

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.37%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 19 →
19
Funds holding
$159607431
Total value held
Buying
14 added · 2 reduced
Janus Henderson Group Plc
$35593891 NEW BUY
Blackrock, Inc.
$33834614 +208.52%
Johnson & Johnson
$32438645 Held
Franklin Resources Inc
$30144931 Held
Goldman Sachs Group Inc
$8150009 +61.92%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
144 20260908 open_in_new SEC.gov
4 20260908 open_in_new SEC.gov
144 20260901 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
144 20260803 open_in_new SEC.gov
144 20260803 open_in_new SEC.gov
4 20260803 open_in_new SEC.gov
10-Q 20260730 open_in_new SEC.gov
8-K 20260730 open_in_new SEC.gov
SCHEDULE 13G 20260727 open_in_new SEC.gov

Frequently asked about CTNM earnings

When does Contineum Therapeutics, Inc. Class A Common Stock report earnings next? expand_more

Contineum Therapeutics, Inc. Class A Common Stock (CTNM)'s next earnings date is approximate for 2026-10-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CTNM stock move after earnings? expand_more

Over 10 reports, CTNM has moved an average of ±4.37% the session after earnings, closing higher 90.0% of the time.

What was CTNM's biggest post-earnings move? expand_more

CTNM's largest post-earnings gain on record was +8.27% on Aug 13, 2024, and its largest decline was -1.65% on Jul 30, 2026.

Where can I find Contineum Therapeutics, Inc. Class A Common Stock's SEC filings? expand_more

All of Contineum Therapeutics, Inc. Class A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers